Why A2 Milk, Orthocell, QBE, and Ramelius shares are pushing higher today

These shares are having a strong finish to the week. But why?

| More on:
Woman with an amazed expression has her hands and arms out with a laptop in front of her.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. At the time of writing, the benchmark index is up 0.35% to 7,997.6 points.

Four ASX shares that are rising more than most today are listed below. Here's why they are climbing:

A2 Milk Company Ltd (ASX: A2M)

The A2 Milk share price is up 2.5% to $8.09. This may have been driven by a broker note out of Citi this morning. According to the note, the broker has reaffirmed its buy rating and $8.20 price target on the infant formula company's shares. The broker highlights that one of A2 Milk's peers in the China market has released a positive update. It believes the update bodes well for the company and particularly the prospects of its new Genesis product range.

Orthocell Ltd (ASX: OCC)

The Orthocell share price is up 4% to $1.54. Investors have been buying this regenerative medicine company's shares this week after it announced the first sales of Striate+ in Germany, Austria and Switzerland. Orthocell's Striate+ is the company's dental guided bone and tissue regeneration product. Management estimates that the global market opportunity for Striate+ is approximately >US$730 million. It notes that the EU and UK markets contribute approximately US$180 million to this. Orthocell is targeting a 20% share of the global market.

QBE Insurance Group Ltd (ASX: QBE)

The QBE share price is up 2.5% to $22.65. This morning, Morgan Stanley retained its overweight rating on this insurance giant's shares with an improved price target of $25.05. The broker is feeling positive about the company's outlook and the insurance industry as a whole. Morgan Stanley also highlights that QBE stands to benefit from increasing demand for cyber insurance with its QCyberProtect offering. The broker's price target implies potential upside of almost 11% for investors over the next 12 months.

Ramelius Resources Ltd (ASX: RMS)

The Ramelius Resources share price is up 6.5% to $2.46. Investors have been buying Ramelius and other ASX gold stocks on Friday following a strong rise in the gold price overnight. The precious metal hit a new record high overnight after US tariffs sparked trade tensions. The spot gold price is currently fetching US$3,082.80, which is up 0.8%. The S&P/ASX All Ordinaries Gold index is up by a sizeable 3.4% at the time of writing.

Should you invest $1,000 in The A2 Milk Company Limited right now?

Before you buy The A2 Milk Company Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and The A2 Milk Company Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk and Orthocell. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Share Gainers

Boss Energy shares have rocketed 90% in a month. Here's why

The massive rally in Boss Energy shares will be painful to the host of short sellers betting against the uranium…

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors sent the market higher once again today.

Read more »

Rising gold share price represented by a green arrow on piles of gold block.
Gold

3 reasons to buy this surging ASX All Ords gold stock today

The ASX All Ords gold stock has doubled investors’ money in 12 months, and this leading expert forecasts more outperformance…

Read more »

Two colleagues at work looking at a tablet and smiling at a rising share price.
Share Gainers

Why Generation Development, Orica, Pro Medicus, and Zip shares are storming higher today

These shares are having a strong session on Thursday. But why?

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Up 114% in a year, why is the Pro Medicus share price leaping higher again on Thursday?

Pro Medicus shares are back in form today and leaping ahead. Here’s why.

Read more »

Man standing on rock next to turquoise salt lagoon.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 finally had a green session this hump day.

Read more »

Man pointing at a blue rising share price graph.
Share Gainers

Guess which ASX 300 stock just rocketed 17%!

Investors are sending the ASX 300 stock soaring higher on Wednesday. But why?

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Firefly, Kelsian, NAB, and Zip shares are roaring higher today

These shares are having a good time on hump day. Let's find out why.

Read more »